Axon Therapy— 510(k) K233364

Substantially Equivalent

Neuralace Medical, Inc.

FDA 510(k) clearance K233364 for Axon Therapy, Substantially Equivalent on 2024-01-10. Applicant: Neuralace Medical, Inc..

Clearance details

Applicant: Neuralace Medical, Inc.
Product code: Code QPL
Advisory panel: Neurology
Date received: 2023-10-02
Decision date: 2024-01-10
Decision: Substantially Equivalent
Clearance type: Traditional
Location: San Diego, CA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.